Pharmaceutical Technology's In the Lab eNewsletter
A new scientific publication examines analytical processes for the emerging legal cannabis industry.
As FDA weighs initial approvals of cannabinoid-based treatments, a growing number of states have legalized marijuana for medicinal and recreational use. Compared with the regulated pharmaceutical environment, the legal cannabis industry is subject to varying state regulations; analytical and quality control guidelines are often lacking.
To fill this gap, a new professional journal and website, Cannabis Science and Technology, was launched in March 2018, in alliance with the Cannabis Science Conference, to educate the legal cannabis industry about the science and technology of analytical testing and quality control.
The publication-a sister publication to Pharmaceutical Technology-will focus on sample preparation techniques for analytical testing; development of analytical methods for potency testing; identification of contaminants such as pesticides, residual solvents, heavy metals, and mycotoxins; quality control for cannabis, extraction, and processing; laboratory best practices and certification; testing standardization; and regulations related to quality control.
The first issue features articles on quality assurance, laboratory accreditation, analytical tools to analyze edibles, metals analysis, and extraction processes. The first issue and subscription information are available on the publication’s website.
Inquiries about editorial submissions can be sent to Meg L’Heureux, Editor-in-Chief.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.